Opko Health, Inc. Closes Offering of $175 Million of 3.00% Convertible Senior Notes Due 2033

Published: Jan 31, 2013

MIAMI--(BUSINESS WIRE)--OPKO Health, Inc. (NYSE: OPK) today announced the closing of its offering of $175.0 million aggregate principal amount of 3.00% convertible senior notes due 2033 (the “Notes”) in a private offering. OPKO intends to use the approximately $170.3 million of net proceeds from this offering for general corporate purposes, including research and development expenses, acceleration of clinical trials, acquisitions of new technologies or businesses, and other business opportunities.

Back to news